Overview

Effect of Antenatal Corticosteroids in Late Preterm

Status:
Unknown status
Trial end date:
2015-11-01
Target enrollment:
0
Participant gender:
Female
Summary
To test the effect on premature infants of a one-time course of betamethasone administered in weeks 34-36 of gestation.
Phase:
Phase 2
Accepts Healthy Volunteers?
Accepts Healthy Volunteers
Details
Lead Sponsor:
Meir Medical Center
Treatments:
Betamethasone
Betamethasone benzoate
Betamethasone sodium phosphate
Betamethasone Valerate
Betamethasone-17,21-dipropionate
Criteria
Inclusion Criteria:

1. Pregnant woman in weeks 34-36 of gestation who did not receive a betamethasone course to
enhance fetal lung maturity during pregnancy 2. Clinical, sonographic or laboratory
suspicion of premature labor 3. Singleton or twin pregnancy

-

Exclusion Criteria:

1. Premature rupture of membranes

2. Fetus with known defects

3. Suspicion of fetal distress

4. Betamethasone administered during pregnancy for any reason